Middle-East and Africa Hypertension Drugs Market is Growing Moderately and Expected to Reach US$ 5.31 Billion By 2022

Pune, India, April, 2017 /MRFR Press Release/- Market research future has a half cooked research report on Middle-East and Africa Hypertension Drugs Market. The market for Middle-East and Africa Hypertension Drugs is growing continuously and expected to grow at a CAGR of 3.1% from 2015 to 2022

Market Highlights

The Middle-East and Africa Hypertension Drugs Market has been evaluated as moderately growing market and it is expected that the market will continue to grow at same pace in the near future. Factors like Stress, unhealthy eating habits, excess use of salt, smoking, and alcohol mainly leads to hypertension. Hypertension or high blood pressure is very harmful and it can damage brain, heart, and kidney as well. High blood pressure can also lead to medical emergencies like stroke and heart attack. Medical professionals recommend drugs as per the current condition of the patient. There are some symptoms of high blood pressure like headache, blood in urine, anxiety etc. Cases of hypertension are growing rapidly in Middle East and Africa. Due to rapid urbanization in the Middle East and Africa, the overall lifestyle, eating habits are changing. Change in lifestyle can show very positive effect to reduce hypertension.  Rising consumer awareness and continuous development of treatment for Hypertension are driving the growth for the Middle-East and Africa Hypertension Drugs market. Major companies are investing amount of money for R&D to find cure for Hypertension. As the number of patients of increasing thus demand for the anti-hypertensive is also increasing rapidly. Increasing spending for healthcare, developing infrastructure, and expanded insurance coverage are leading the growth for Middle-East and Africa Hypertension Drugs. Middle-East and Africa Hypertension Drugs Market was estimated around US$ 4.52 billion in 2015 and is expected to reach US$ 5.31 billion by 2022 at a CAGR of 3.1%. There are several factors which are prohibiting the growth of the market such as high cost of treatment and drugs, lack of early treatment, people mostly from some African countries are not much aware about the symptoms of high blood pressure etc.

Test the market data and market information presented through more than 60 market data tables and figures spread over 55 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Middle-East and Africa Hypertension Drugs Market Research Report –Forecast to 2022.”

Access Report Details @ https://www.marketresearchfuture.com/reports/hypertension-drugs-market-2636  

Hypertension Drugs Market Players:

Abbott (US), Johnson & Johnson Services, Inc. (US), Novartis (Switzerland), GlaxoSmithKline plc. (UK), AstraZeneca (UK), Bayer AG (Germany), Pfizer Inc.(US), Merck & Co., Inc. (US), Sanofi (France), F. Hoffmann-La Roche Ltd (Switzerland), Gilead (US)

Regional Analysis

Considering the Middle-East and Africa Hypertension Drugs Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Hypertension Drugs. Moreover Saudi Arabia market is also growing and second largest market for Hypertension Drugs. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Hypertension Drugs during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.

Segmentation:

Middle-East and Africa Hypertension Drugs Market has been segmented on the basis of type which comprise Thiazide diuretics, Beta blockers, Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II receptor blockers, Calcium channel blockers, Renin inhibitors, Alpha blockers, Alpha-beta blockers, Central-acting agents, Vasodilators, Aldosterone antagonists, and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com